India Pharma Outlook Team | Thursday, 14 August 2025
Max Healthcare Institute Ltd. is set to invest Rs 6,000 crore by 2028 to significantly expand its hospital network across India, adding 3,700 new beds.
This move will grow its current setup of 22 hospitals, which have around 5,000 beds, to about 30 facilities. The announcement came from Abhay Soi, the company’s Chairman and Managing Director, during the opening of a new 300-bed Max Super Speciality Hospital in Dwarka, Delhi.
The Dwarka hospital is well positioned to serve the Delhi-NCR market with more than 120 critical care beds, 10 modern operating theatres, and cutting edge Cath Labs.
Also Read: Building a Successful Pharma Brand in India: The Role of Scientific Communication
It also specializes in heart care, cancer, kidney diseases, brain and nerve conditions, robotic surgery, pediatrics, organ transplants, and several other clinical conditions, establishing it as an important health care hub due to connectivity. Max Healthcare has plans to develop additional hospitals in Mohali, Mumbai, Saket New Delhi, which will open in 2025, as well as upgrade existing hospitals.
This expansion will be completely funded by company profits and does not rely on outside external loans. Of all the new beds, almost 76% will be in large urban cities and the other 24% will be in smaller Tier-2 cities and will help to address the urgent need for quality healthcare. Max Healthcare is also keeping the lookout for acquisition opportunities and has included a separate budget for that.
The growth plan is a representation of Max’s commitment to meeting India’s growing healthcare demands, especially in an area of advanced medical care, and also establishes it as a leading and reputable healthcare brand in the country.
